Early Alzheimer's Clinical Trials

Join Our Early Alzheimer's Clinical Research Trial

We are conducting a clinical trial to evaluate a new investigational medicine for people with early Alzheimer’s disease (AD). Alzheimer’s is the most common cause of memory loss and dementia worldwide, and its impact continues to grow. Recent studies suggest that treating AD in its early stages can be most effective

Study Overview
Purpose: This study aims to assess how well a new investigational medicine works, how safe it is, and how well it is tolerated compared to a placebo. We are focusing on delaying the progression of Alzheimer’s symptoms.

Who Can Participate?
We are looking for:

Adults aged 50 to 80.
Diagnosed with mild cognitive impairment (MCI) or mild Alzheimer’s dementia.

Study Duration
This study will last for 8 weeks.

Additional Information: Participants can have a loved one or caregiver join them as a study partner. Join us in exploring new pathways that could make a difference for those living with early Alzheimer’s.

Eligibility Checker:

Name *

Email *

Confirm Email

Phone *

Address

Address Line 1

Address Line 2

City

State / Province / Region

Postal Code

Country

Date Of Birth *

Best time to call: *

Nearest Panthera Clinic *

Study Partner Name

Study Partner Phone

Study Partner Email

Confirm Email

Do you consent to the collection and processing of your personal data in accordance with the GDPR for the purposes stated in our privacy policy? *

By clicking submit, you are confirming that you have read & understood the Privacy Policy

Interested in Clinical Trials?

Explore opportunities to participate in our clinical trials. Click the link below to register your interest and receive updates about new and upcoming studies that match your health interests. Your involvement can contribute to groundbreaking medical research and the development of innovative treatments.

Register Now for Clinical Trial Updates